Advantage Alpha Capital Partners LP Veracyte, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $361 Million
- Q1 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 26,284 shares of VCYT stock, worth $732,009. This represents 0.22% of its overall portfolio holdings.
Number of Shares
26,284
Previous 17,129
53.45%
Holding current value
$732,009
Previous $678,000
14.9%
% of portfolio
0.22%
Previous 0.18%
Shares
6 transactions
Others Institutions Holding VCYT
# of Institutions
306Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$217 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$146 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$110 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$107 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.99B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...